Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+
July 22, 2025 02:00 ET Â | Source: Scancell Holdings Plc SCOPE trial…
Bridge Capture enables sensitive, scalable liquid biopsy in colorectal cancer pilot
Clinical study in Scientific Reports shows Bridge Captureâ„¢ detects key mutations from…
The Lamborghini Temerario GT3 Born and bred in SantAgata Bolognese
Introducing the first race car derived from the Temerario road modelFirst competition…
Kia Announces Pricing for 2026 Kia K5
Kia America has announced pricing for the 2026 Kia K5. A boldly…
Medidata and the University of Sydney’s NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia
Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering…
Revenera Achieves ISO 27001 Certification of its Information Security Management System (ISMS)
ITASCA, Ill., July 09, 2025 (GLOBE NEWSWIRE) -- Revenera, a division of…
Novotech Earns Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class…
The Ensign Group Purchases Skilled Nursing Facility in Texas
July 02, 2025 06:00 ET Â | Source: The Ensign Group, Inc. SAN…
The Ensign Group Continues Growth in Idaho
July 02, 2025 06:00 ET Â | Source: The Ensign Group, Inc. SAN…
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)
QIAGEN to create a multimodal panel using next-generation sequencing (NGS) technology for…